Profile: Notal Vision Ltd. provides diagnostic solutions for the early detection and monitoring of age-related macular degeneration. Our products include Foreseehome™ and Foresee PHP®. Our Foresee Preferential Hyperacuity Perimeter® system is indicated as a diagnostic aid for the detection and monitoring of the progression of age-related macular degeneration (AMD)including, but not limited to, the detection of choroidal neovascularization (CNV). This is a non-invasive visual field analyzer for monitoring AMD and for the early detection of conversion to choroidal neovascularization. The Foreseehome™ is intended for use in the detection and characterization of central and paracentral metamorphopsia (visual distortion) in patients with age-related macular degeneration, as an aid in monitoring progression of disease factors causing metamorphopsia including but not limited to choroidal neovascularization (CNV). Our Foresee PHP® test consists of a series of dot deviation signals flashed at predefined intervals, across the central 14° of the patient's macular vision. This projection of a dot deviation signal on a retinal lesion can cause the patient to perceive distortion, scotoma, and/or blurring of part of the line. We offer Foresee PHP® system with a screen-based application, which runs on the Foresee PHP® device and the patient's responses are recorded and analyzed by a pre-designed algorithm in it.

FDA Registration Number: 3004103096
US Agent: Susan Orr / Notalvision Inc
Phone: +1-(703)-703-9533  E-Mail: